Zhu Y, Yuan T, Zhang Y, Shi J, Bai L, Duan X, . . . Zhong L. (2019). AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma. Dove Medical Press.
Chicago Style (17th ed.) CitationZhu Y, Yuan T, Zhang Y, Shi J, Bai L, Duan X, Tong R, and Zhong L. AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma. Dove Medical Press, 2019.
MLA (9th ed.) CitationZhu Y, et al. AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma. Dove Medical Press, 2019.
Warning: These citations may not always be 100% accurate.